RLYB
Rallybio Corp
NASDAQ · Healthcare · Biotechnology · US
$16.35
+0.43%Jun 1, 2026, 12:00 UTC
Rallybio Corporation agreed to acquire Avenzo Therapeutics, Inc. through a merger.
Source:
NASDAQ · Healthcare · Biotechnology · US
Jun 1, 2026, 12:00 UTC